. "1"^^ . . . . . . . . . . . . "Jin\u00E9 l\u00E9kov\u00E9 interakce\nP\u0159i u\u017E\u00EDv\u00E1n\u00ED cyklosporinu s\u00A0jin\u00FDmi l\u00E9ky je t\u0159eba v\u011Bnovat zv\u00FD\u0161enou pozornost l\u00E9k\u016Fm, kter\u00E9 maj\u00ED nefrotoxick\u00FD synergistick\u00FD \u00FA\u010Dinek: nap\u0159. aminoglykosidy (nap\u0159. gentamicin, tobramycin), amfotericin B, ciprofloxacin, vankomycin, trimetoprim (+ sulfametoxazol); nesteroidn\u00ED antirevmatika (nap\u0159. diklofenak, naproxen, sulindak); melfalan, antagonist\u00E9 H2 receptor\u016F (nap\u0159. cimetidin, ranitidin); methotrex\u00E1t (viz bod 4.4. Zvl\u00E1\u0161tn\u00ED upozorn\u011Bn\u00ED a opat\u0159en\u00ED pro pou\u017Eit\u00ED)."@cs . . . . . . . . . "32145"^^ . "31667"^^ .